Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 05, 2021

SELL
$102.3 - $112.62 $214,216 - $235,826
-2,094 Closed
0 $0
Q4 2020

Feb 01, 2021

BUY
$80.49 - $108.67 $168,546 - $227,554
2,094 New
2,094 $224,000
Q3 2020

Nov 03, 2020

SELL
$85.91 - $100.83 $179,895 - $211,138
-2,094 Closed
0 $0
Q2 2020

Jul 07, 2020

BUY
$73.37 - $98.18 $153,636 - $205,588
2,094 New
2,094 $206,000
Q1 2020

Apr 28, 2020

SELL
$64.5 - $97.79 $160,863 - $243,888
-2,494 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $179,892 - $225,083
2,494 New
2,494 $221,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Watchman Group, Inc. Portfolio

Follow Watchman Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Watchman Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Watchman Group, Inc. with notifications on news.